Aplenzin 522 mg/1 (Bupropion Hydrobromide TABLET, EXTENDED RELEASE) 522 mg/1

Aplenzin 522 mg is an extended-release tablet containing bupropion hydrobromide, used for depression and smoking cessation. Learn about its uses, effects, and precautions.

Strength

522 mg/1

Pack Size

7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aplenzin 522 mg is primarily used to treat major depressive disorder and aid in smoking cessation. Bupropion hydrobromide, the active ingredient, works to balance certain chemicals in the brain. This medication is often prescribed for individuals seeking relief from depressive symptoms or looking to quit smoking. Always consult a healthcare provider to determine if Aplenzin is suitable for your specific needs.

Side Effects

Common effects of Aplenzin 522 mg may include dry mouth, nausea, and insomnia. Some users report increased energy levels or changes in appetite. As with any medication, individual experiences can vary. If you notice severe or persistent side effects, it's important to discuss them with your healthcare provider.

Precautions & Warnings

Aplenzin 522 mg should be handled with care, especially if you have a history of seizures, eating disorders, or bipolar disorder. It's crucial to follow your healthcare provider's instructions regarding dosage and administration. Avoid abrupt discontinuation without medical advice, as this can lead to withdrawal symptoms.

Avoid Interactions

Aplenzin 522 mg may interact with certain medications, including MAO inhibitors, other antidepressants, and drugs that affect brain chemicals. Alcohol consumption should be avoided while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Aplenzin 522 mg is used to treat major depressive disorder and aid in smoking cessation. It works by balancing certain chemicals in the brain.

Aplenzin 522 mg is an extended-release tablet taken orally, usually once daily. Follow your healthcare provider's instructions for the best results.

Common side effects include dry mouth, nausea, and insomnia. Severe or persistent side effects should be discussed with your healthcare provider.

It is advisable to avoid alcohol while taking Aplenzin 522 mg, as it can increase the risk of side effects.

If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.